Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03035253
Title A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Fluorouracil + Irinotecan + Leucovorin + Navicixizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.